6-HYDROXYDOPAMINE LESION OF THE RAT SUBSTANTIA-NIGRA - TIME-COURSE AND MORPHOLOGY OF CELL-DEATH

被引:203
|
作者
JEON, BS
JACKSONLEWIS, V
BURKE, RE
机构
[1] SEOUL NATL UNIV HOSP,DEPT NEUROL,SEOUL 110744,SOUTH KOREA
[2] COLUMBIA UNIV,COLL PHYS & SURG,DEPT NEUROL,NEW YORK,NY 10027
来源
NEURODEGENERATION | 1995年 / 4卷 / 02期
关键词
CELL DEATH; DOPAMINERGIC; 6-HYDROXYDOPAMINE; SILVER STAINING; SUBSTANTIA NIGRA;
D O I
10.1006/neur.1995.0016
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The 6-hydroxydopamine (6-OHDA) model of nigral injury in rats has been in use as a standard animal model of parkinsonism for many years. While earlier studies established the time course for loss of catecholamine histofluorescence or tyrosine hydroxylase immunostaining in the cell bodies and terminals, these alterations in phenotypic expression do not define the time course of morphologic degeneration. We have therefore used a silver impregnation method to characterize the time course and morphology of the degeneration of neurons in the nigrostriatal system. Abundant neuronal death was observed in substantia nigra pars compacta (SNpc) as early as 12 hours after nigral 6-OHDA injection, and prior to any evidence of striatal terminal degeneration. From 1 to 7 days neuron death was accompanied by striatal fibre degeneration. After 7 days, fibre degeneration was no longer seen, but identifiable neuron death continued at low levels for as long as 31 days, and stained amorphous material was present at 60 days. The morphologic pattern of cell death in the early phase was similar to that in the late phase, and included cytoplasmic silver deposits and dark staining of the nucleolus. At no time was the morphology of apoptosis observed. We conclude that neuron death is a progressive process following 6-OHDA lesion, with similar morphology throughout the course of degeneration.
引用
收藏
页码:131 / 137
页数:7
相关论文
共 47 条
  • [21] Time-course of brain oxidative damage caused by intrastriatal administration of 6-hydroxydopamine in a rat model of Parkinson's disease
    Sanchez-Iglesias, Sofia
    Rey, Pablo
    Mendez-Alvarez, Estefania
    Labandeira-Garcia, Jose Luis
    Soto-Otero, Ramon
    NEUROCHEMICAL RESEARCH, 2007, 32 (01) : 99 - 105
  • [22] Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease
    Marinova-Mutafchieva, Lilia
    Sadeghian, Mona
    Broom, Lauren
    Davis, John B.
    Medhurst, Andrew D.
    Dexter, David T.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 (03) : 966 - 975
  • [23] Time-Course of Brain Oxidative Damage Caused by Intrastriatal Administration of 6-Hydroxydopamine in a Rat Model of Parkinson’s Disease
    Sofía Sánchez-Iglesias
    Pablo Rey
    Estefanía Méndez-Álvarez
    José Luis Labandeira-García
    Ramón Soto-Otero
    Neurochemical Research, 2007, 32 : 99 - 105
  • [24] REGULATION OF NEUROTENSIN-CONTAINING NEURONS IN THE RAT STRIATUM AND SUBSTANTIA NIGRA - EFFECTS OF UNILATERAL NIGRAL LESION WITH 6-HYDROXYDOPAMINE ON NEUROTENSIN CONTENT AND ITS BINDING-SITE DENSITY
    MASUO, Y
    PELAPRAT, D
    MONTAGNE, MN
    SCHERMAN, D
    ROSTENE, W
    BRAIN RESEARCH, 1990, 510 (02) : 203 - 210
  • [25] In vivo electrochemical studies of dopamine clearance in the rat substantia nigra: Effects of locally applied uptake inhibitors and unilateral 6-hydroxydopamine lesions
    Hoffman, AF
    Gerhardt, GA
    JOURNAL OF NEUROCHEMISTRY, 1998, 70 (01) : 179 - 189
  • [26] TIME-COURSE OF NIGROSTRIATAL NEURODEGENERATION AND NEUROINFLAMMATION IN THE 6-HYDROXYDOPAMINE-INDUCED AXONAL AND TERMINAL LESION MODELS OF PARKINSON'S DISEASE IN THE RAT
    Walsh, S.
    Finn, D. P.
    Dowd, E.
    NEUROSCIENCE, 2011, 175 : 251 - 261
  • [27] Time-course behavioral features are correlated with Parkinson's disease-associated pathology in a 6-hydroxydopamine hemiparkinsonian rat model
    Su, Rui-Jun
    Zhen, Jun-Li
    Wang, Wei
    Zhang, Jian-Liang
    Zheng, Yan
    Wang, Xiao-Min
    MOLECULAR MEDICINE REPORTS, 2018, 17 (02) : 3356 - 3363
  • [28] Differential effects of intrastriatal 6-hydroxydopamine on cell number and morphology in midbrain dopaminergic subregions of the rat
    Healy-Stoffel, Michelle
    Ahmad, S. Omar
    Stanford, John A.
    Levant, Beth
    BRAIN RESEARCH, 2014, 1574 : 113 - 119
  • [29] Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra
    Elizabeth Knyihár-Csillik
    Zoltan Chadaide
    András Mihály
    Beata Krisztin-Péva
    Robert Fenyő
    László Vécsei
    Acta Neuropathologica, 2006, 112 : 127 - 137
  • [30] Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra
    Knyihar-Csillik, Elizabeth
    Chadaide, Zoltan
    Mihaly, Andras
    Krisztin-Peva, Beata
    Fenyo, Robert
    Vecsei, Laszlo
    ACTA NEUROPATHOLOGICA, 2006, 112 (02) : 127 - 137